GNL Gut and Liver
  1. Yao-Chun Hsu, Mike T. Wei, Mindie H. Nguyen. Tenofovir alafenamide as compared to tenofovir disoproxil fumarate in the management of chronic hepatitis B with recent trends in patient demographics. Expert Review of Gastroenterology & Hepatology 2017;11:999
    https://doi.org/10.1080/17474124.2017.1386554
  2. Jian Wang, Tao Fan, Shaoqiu Zhang, Chao Wu, Rui Huang. Letter: Impact of antiviral treatment on renal function in patients with chronic hepatitis B. Aliment Pharmacol Ther 2024;59:1012
    https://doi.org/10.1111/apt.17922
  3. Elizabeth C. Verna. Updated Hepatitis B Guidance: Implications for liver transplant patients. Liver Transpl 2018;24:465
    https://doi.org/10.1002/lt.25037
  4. Tae Seop Lim, Jae Seung Lee, Beom Kyung Kim, Hye Won Lee, Mi Young Jeon, Seung Up Kim, Jun Yong Park, Do Young Kim, Kwang‐Hyub Han, Sang Hoon Ahn. An observational study on long‐term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate. Journal of Viral Hepatitis 2020;27:316
    https://doi.org/10.1111/jvh.13222
  5. Qing-Lei Zeng. Pharmacotherapy for Liver Cirrhosis and Its Complications. 2020.
    https://doi.org/10.1007/978-981-19-2615-0_1
  6. Mei-Juan Peng, Xiao-Qing Guo, Wei-Lu Zhang, Jing Chen, Wen Kang, Xiao-Fei Yang, Ying Guo, Ye Zhang. Effect of pegylated interferon-α2b add-on therapy on renal function in chronic hepatitis B patients: A real-world experience. Front. Microbiol. 2022;13
    https://doi.org/10.3389/fmicb.2022.980250
  7. Sam Trinh, An K. Le, Ellen T. Chang, Joseph Hoang, Donghak Jeong, Mimi Chung, Mei-Hsuan Lee, Uerica Wang, Linda Henry, Ramsey Cheung, Mindie H. Nguyen. Changes in Renal Function in Patients With Chronic HBV Infection Treated With Tenofovir Disoproxil Fumarate vs Entecavir. Clinical Gastroenterology and Hepatology 2019;17:948
    https://doi.org/10.1016/j.cgh.2018.08.037
  8. Vinh Vu, Sam Trinh, An Le, Tiffani Johnson, Joseph Hoang, Donghak Jeong, Linda Henry, Scott Barnett, Ramsey Cheung, Mindie H. Nguyen. Hepatitis B and renal function: A matched study comparing non‐hepatitis B, untreated, treated and cirrhotic hepatitis patients. Liver International 2019;39:655
    https://doi.org/10.1111/liv.14009
  9. Sang Jin Kim, Jinsoo Rhu, Seo Hee Lee, Jong Man Kim, Gyu-Seong Choi, Kyunga Kim, Jae-Won Joh. Tenofovir does not induce renal dysfunction compared to entecavir in post-liver-transplant hepatitis B virus patients. Ann Surg Treat Res 2020;99:180
    https://doi.org/10.4174/astr.2020.99.3.180
  10. Hui Zheng, Haidong Liu, Anhua Hao, Min Zhang, Dexin Wang. Association between serum Cystatin C and renal injury in patients with chronic hepatitis B. 2020;99:e21551
    https://doi.org/10.1097/MD.0000000000021551
  11. Ya-Hui Huang, Chau-Ting Yeh, Chao-Wei Hsu, Yang-Hsiang Lin. Reduction of ACE2 Serum Concentrations by Telbivudine in Chronic Hepatitis B Patients. CMM 2023;23:420
    https://doi.org/10.2174/1566524022666220510220533
  12. Sang Hoon Ahn, Won Kim, Young Kul Jung, Jin Mo Yang, Jae Young Jang, Yong Oh Kweon, Yong Kyun Cho, Yoon Jun Kim, Gun Young Hong, Dong Joon Kim, Soon Ho Um, Joo Hyun Sohn, Jin Woo Lee, Sung Jae Park, Byung Seok Lee, Ju Hyun Kim, Hong Soo Kim, Seung Kew Yoon, Moon Young Kim, Hyung Joon Yim, Kwan Sik Lee, Young Suk Lim, Wan Sik Lee, Neung Hwa Park, So Young Jin, Kyun-Hwan Kim, Won Choi, Kwang-Hyub Han. Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus Infection. Clinical Gastroenterology and Hepatology 2019;17:1850
    https://doi.org/10.1016/j.cgh.2018.11.001
  13. Jie Luo, Xu You, Yutian Chong, Yuankai Wu, Jiao Gong, Yusheng Jie, Xinhua Li, Sujuan Xi, Zhiwei Zhang, Yufeng Zhang, Dongying Xie, Zhanyi Li, Xiangyong Li. Efficacy of long‑term treatment with tenofovir in Chinese nucleos(t)ide‑na�ve chronic hepatitis B patients regardless of baseline viral load. Exp Ther Med 2019
    https://doi.org/10.3892/etm.2019.7547
  14. Dohyeong Lee, Byung Cheol Yun, Kwang Il Seo, Byung Hoon Han, Sang Uk Lee, Eun Taek Park, Jin Wook Lee, Joonho Jeong. Risk factors associated with hypophosphatemia in chronic Hepatitis B patients treated with tenofovir disoproxil fumarate. 2019;98:e18351
    https://doi.org/10.1097/MD.0000000000018351
  15. Mustafa Arısoy, Mehtap Saydam, Yasemin Ekin Dolaksız, Özge Demirbaş, Çağrı Talay, Onursal Sağlam, Gökçe Demiray, Emel Doğan Kurtoğlu, Ayşe Nur Oktay. Evaluation of Pharmacokinetics of a BCS Class III Drug with Two Different Study Designs: Tenofovir Alafenamide Monofumarate Film-coated Tablet. AAPS PharmSciTech 2024;25
    https://doi.org/10.1208/s12249-024-02835-5
  16. Norah A. Terrault, Anna S.F. Lok, Brian J. McMahon, Kyong‐Mi Chang, Jessica P. Hwang, Maureen M. Jonas, Robert S. Brown, Natalie H. Bzowej, John B. Wong. Update on prevention, diagnosis, and treatment of chronic hepatitis B. 2018;67:1560
    https://doi.org/10.1002/hep.29800
  17. Maria Buti, Luisa Roade, Mar Riveiro‐Barciela, Rafael Esteban. Optimal management of chronic hepatitis B patients receiving nucleos(t)ide analogues. Liver International 2020;40:15
    https://doi.org/10.1111/liv.14367
  18. Hyunwoo Oh, Dae Won Jun. Can We Trust Safety of Tenofovir Disoproxil in Patients with Decompensated Cirrhosis?. Gut and Liver 2017;11:743
    https://doi.org/10.5009/gnl17401
  19. Helen Te, Karen Doucette. Viral hepatitis: Guidelines by the American Society of Transplantation Infectious Disease Community of Practice. Clinical Transplantation 2019;33
    https://doi.org/10.1111/ctr.13514
  20. Alessandra M. de A. Maciel, Maria Lucia C. G. Ferraz, Renata de M. Perez, Carlos Eduardo Brandão-Mello. Renal dysfunction during treatment of chronic hepatitis B with tenofovir disoproxyl fumarate and associated risk factors. 2024;36:482
    https://doi.org/10.1097/MEG.0000000000002723
  21. Zhili Wen, Yuliang Feng, Xiaohua Yan. Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B. Journal of Hepatology 2021;74:245
    https://doi.org/10.1016/j.jhep.2020.07.038
  22. Hyo-Young Lee, Hyunwoo Oh, Chan-Hyuk Park, Yee-Hui Yeo, Mindie H Nguyen, Dae-Won Jun. Comparison of renal safety of tenofovir and entecavir in patients with chronic hepatitis B: Systematic review with meta-analysis. WJG 2019;25:2961
    https://doi.org/10.3748/wjg.v25.i23.2961
  23. Young Eun Chon, Soo Young Park, Seung Up Kim, Han Pyo Hong, Jae Seung Lee, Hye Won Lee, Mi Na Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim. Long‐term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study. Journal of Viral Hepatitis 2022;29:289
    https://doi.org/10.1111/jvh.13656
  24. Xiaoxian Yang, Haiyi Yan, Xiuju Zhang, Xueying Qin, Peng Guo. Comparison of renal safety and bone mineral density of tenofovir and entecavir in patients with chronic hepatitis B: a systematic review and meta-analysis. International Journal of Infectious Diseases 2022;124:133
    https://doi.org/10.1016/j.ijid.2022.09.021
© 2023. Gut and Liver. / Powered by INFOrang Co., Ltd